You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Novartis
Pharmaceuticals
Novo Nordisk
Eli Lilly
Johnson and Johnson
GSK
AstraZeneca
Genentech
Pfizer
Topics

Advertisement

Novartis

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

Curium knocks out Novartis cancer drug patents in generics fight Bloomberg Law 7d

Bloomberg Law 7d

ASCO: Novartis To Face Challengers In Growing Radiopharmaceutical Space Scrip Pharma Intelligence 19:35 Thu, 11 Jun

Scrip Pharma Intelligence 19:35 Thu, 11 Jun

Stat Plus: Novartis doubles down on molecular glue strategy STAT 15:13 Thu, 11 Jun

STAT 15:13 Thu, 11 Jun

Positive Del-brax biomarker data offers early support for Novartis’s Avidity bet Scrip Pharma Intelligence 14:19 Thu, 11 Jun

Scrip Pharma Intelligence 14:19 Thu, 11 Jun

Advertisement

Novartis $12bn bet on Avidity well placed after mid-stage FSHD win Clinical Trials Arena 16:21 Thu, 11 Jun

Clinical Trials Arena 16:21 Thu, 11 Jun

Novartis' Rhapsido meets primary goal in Phase III skin disorder study Zacks 16:38 Mon, 15 Jun

Zacks 16:38 Mon, 15 Jun

Advertisement

Advertisement

Latest

Yesterday

Antares, Novartis pursuing undruggable cancer targets in $1.9B deal BioWorld 21:49 Wed, 24 Jun

Bristol Myers Follows Novartis, Sues Arkansas Over Pharmacy Law Bloomberg Law 19:37 Wed, 24 Jun

Novartis targets undruggable cancers with $1.9bn Antares Therapeutics deal Pharmaceutical Technology 15:32 Wed, 24 Jun

Becoming rentABLE Joins Novartis' "SMAshing My Limits And Going Places" Campaign to Expand Accessible Lodging for People Living with SMA PR Newswire (Press Release) 13:01 Wed, 24 Jun

Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies Business Wire (Press Release) 12:01 Wed, 24 Jun

Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly's Zacks 10:38 Wed, 24 Jun

South San Francisco Biotech Giant Dragged Into Nationwide Xolair Kickback Showdown Hoodline 06:09 Wed, 24 Jun

Tuesday

Keck School of Medicine of USC and Novartis collaborate to eliminate breast cancer screening barriers News-Medical.Net 19:40 Tue, 23 Jun

A string of disputes reveals how Novartis leverages litigation to protect trade secrets IAM 13:00 Tue, 23 Jun

“Voice for Her Power” Unites Sectors to Advance Equity in Breast Cancer Care Bangkok Post 03:56 Tue, 23 Jun

Advertisement

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis